Pages that link to "Q44053906"

The following pages link to A double-blind placebo-controlled trial of topiramate treatment for essential tremor (Q44053906):

Displaying 46 items.

• Alprazolam for essential tremor (Q24201430) (← links)
• Zonisamide for essential tremor (Q24201497) (← links)
• Pregabalin for essential tremor (Q24203614) (← links)
• Beta blockers for essential tremor (Q24241056) (← links)
• Differential diagnosis of common tremor syndromes (Q24680120) (← links)
• The treatment of tremor (Q27022935) (← links)
• Essential tremor. (Q33448113) (← links)
• Treatment of patients with essential tremor (Q34025450) (← links)
• Pharmacological Management of Essential Tremor (Q34150090) (← links)
• Postural induced-tremor in psychiatry (Q34601607) (← links)
• Pharmacologic management of essential tremor. (Q34617734) (← links)
• Use of antiepileptic drugs for hyperkinetic movement disorders (Q34829294) (← links)
• Tremor - Easily Seen but Difficult to Describe and Treat (Q35105756) (← links)
• Benefits and Risks of Pharmacological Treatments for Essential Tremor (Q35123386) (← links)
• Guidelines for management of essential tremor (Q35153016) (← links)
• Essential tremor: differential diagnosis and current therapy (Q35189759) (← links)
• Oral pharmacotherapy of childhood movement disorders (Q35292308) (← links)
• Essential tremor: diagnosis and treatment. (Q35549753) (← links)
• The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. (Q35824087) (← links)
• A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders (Q36178486) (← links)
• Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management (Q36235520) (← links)
• Drug-induced tremors (Q36317590) (← links)
• Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy (Q37029357) (← links)
• Hypothetical membrane mechanisms in essential tremor (Q37035840) (← links)
• Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate (Q37164665) (← links)
• Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials (Q37176201) (← links)
• Pharmacotherapy of essential tremor : an overview of existing and upcoming agents (Q37322233) (← links)
• Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders (Q37724363) (← links)
• What's the role of topiramate in the management of patients with hyperkinetic movement disorders? (Q38009653) (← links)
• Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management (Q38085546) (← links)
• Safety of topiramate for treating migraines (Q38237259) (← links)
• The GABA Hypothesis in Essential Tremor: Lights and Shadows (Q38239686) (← links)
• Linking Essential Tremor to the Cerebellum: Neurochemical Evidence (Q38615853) (← links)
• Topiramate for essential tremor. (Q38836991) (← links)
• Overview of essential tremor (Q41765411) (← links)
• Effects of topiramate in patients with cerebellar tremor (Q44589871) (← links)
• Topiramate concentration in saliva: an alternative to serum monitoring (Q44633284) (← links)
• Vascular hemichorea/hemiballism and topiramate (Q44979274) (← links)
• Improvement of cervico-trunco-brachial segmental dystonia with topiramate (Q46835782) (← links)
• Effects of topiramate on the prepulse inhibition of the acoustic startle in rats (Q48489390) (← links)
• Essential tremor: treatment options (Q48602274) (← links)
• Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). (Q50277443) (← links)
• Is the anticonvulsant topiramate beneficial in essential tremor? (Q50278112) (← links)
• [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment] (Q91918711) (← links)
• Commentary (Q93607015) (← links)
• Essential tremor (Q94393774) (← links)